These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2917589)

  • 21. Liquid formulations of 8-methoxypsoralen (8-MOP) and 5-MOP: a prospective double-blind crossover assessment of acute non-phototoxic adverse effects.
    George SA; Ferguson J
    Photodermatol Photoimmunol Photomed; 1992 Feb; 9(1):33-5. PubMed ID: 1390121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frameshift mutagenesis in bacteria by 8-methoxypsoralen (methoxalen) in the dark.
    Bridges BA; Mottershead RP
    Mutat Res; 1977 Sep; 44(3):305-12. PubMed ID: 333279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psoralens in association with seasonal affective disorder.
    Partonen T
    Med Hypotheses; 1998 Jun; 50(6):481-2. PubMed ID: 9710320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chromosome damage induced in human lymphocytes by 5-methoxypsoralen and 8-methoxypsoralen plus UV-A.
    Abel G
    Mutat Res; 1987 Jan; 190(1):63-8. PubMed ID: 3796673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparison of photomutagenic activities of 5-mop (bergapten) and 8-mop (xanthotoxin) in chlamydomonas reinhardii (author's transl)].
    Schimmer O
    Mutat Res; 1981 Aug; 89(4):283-96. PubMed ID: 7290096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Photochemotherapy (PUVA) and psoriasis: comparison of 8-MOP and 8-MOP/5-MOP.
    Langner A; Wolska H; Kowalski J; Duralska H; Murawska E
    Int J Dermatol; 1976 Nov; 15(9):688-9. PubMed ID: 977210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dark effect of 8-methoxypsoralen on human erythrocytes.
    Gawron A; Pawlikowska B
    J Pharm Pharmacol; 1993 Dec; 45(12):1087-9. PubMed ID: 7908980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthetically modified methoxsalen for enhanced cytotoxicity in light and dark reactions.
    Guillon CD; Jan YH; Foster N; Ressner J; Heck DE; Laskin JD; Heindel ND
    Bioorg Med Chem Lett; 2019 Feb; 29(4):619-622. PubMed ID: 30638875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The classical photoactivated drug 8-methoxypsoralen and related compounds are effective without UV light irradiation against glioma cells.
    de Oliveira DM; Ferreira Lima RM; Clarencio J; Velozo EDS; de Amorim IA; Andrade da Mota TH; Costa SL; Silva FP; El-Bachá RDS
    Neurochem Int; 2016 Oct; 99():33-41. PubMed ID: 27292695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-Methoxypsoralen as a specific stimulating agent of melatonin secretion in humans.
    Souetre E; Salvati E; Belugou JL; Krebs B; Darcourt G
    J Clin Endocrinol Metab; 1990 Sep; 71(3):670-4. PubMed ID: 2394773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of 8-methoxypsoralen in the dark on proliferation of stimulated lymphocytes.
    Górski G; Antosz H; Gawron A
    J Pharm Pharmacol; 1991 Jan; 43(1):63-4. PubMed ID: 1676067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of oral photochemotherapy (8-methoxypsoralen + UVA) on the electrophysiologic function of retina.
    Shoeibi N; Taheri A; Nikandish M; Omidtabrizi A; Khosravi N; Kadkhoda M; Moghaddam SG
    Cutan Ocul Toxicol; 2016; 35(2):104-9. PubMed ID: 25942691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative bacterial mutagenicity studies with 8-methoxypsoralen and 4,5',8-trimethylpsoralen in the presence of near-ultraviolet light and in the dark.
    Kirkland DJ; Creed KL; Mannisto P
    Mutat Res; 1983 Feb; 116(2):73-82. PubMed ID: 6338360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 8-methoxypsoralen reduces AKT phosphorylation, induces intrinsic and extrinsic apoptotic pathways, and suppresses cell growth of SK-N-AS neuroblastoma and SW620 metastatic colon cancer cells.
    Bartnik M; Sławińska-Brych A; Żurek A; Kandefer-Szerszeń M; Zdzisińska B
    J Ethnopharmacol; 2017 Jul; 207():19-29. PubMed ID: 28627461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Role of electroretinography in the prognosis of central retinal vein occlusion].
    Dujić M; Nikolić Lj
    Srp Arh Celok Lek; 1997; 125(7-8):214-8. PubMed ID: 9304234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism-based inactivation of cytochrome P450 2B1 by 8-methoxypsoralen and several other furanocoumarins.
    Koenigs LL; Trager WF
    Biochemistry; 1998 Sep; 37(38):13184-93. PubMed ID: 9748325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The duplex nature of the retina of the nocturnal gecko as reflected in the electroretinogram.
    DODT E; JESSEN KH
    J Gen Physiol; 1961 Jul; 44(6):1143-58. PubMed ID: 13723366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genotoxic effects and DNA photoadducts induced in Chinese hamster V79 cells by 5-methoxypsoralen and 8-methoxypsoralen.
    Papadopoulo D; Averbeck D
    Mutat Res; 1985 Sep; 151(2):281-91. PubMed ID: 4033682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bath-5-methoxypsoralen-UVA therapy for psoriasis.
    Calzavara-Pinton PG; Zane C; Carlino A; De Panfilis G
    J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):945-9. PubMed ID: 9204060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simple equilibrium dialysis-high-performance liquid chromatographic method for the in vitro assessment of 5-methoxypsoralen bound to human albumin.
    Makki S; Muret P; Renaud A; Agache P; Magnin P
    J Chromatogr; 1991 Feb; 539(2):443-8. PubMed ID: 2045454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.